New agents for Gram-positive bacteria

被引：63

作者：

Bhavnani, SM ^{[1
]}

Ballow, CH

机构：

[1] Kaleida Hlth Millard Fillmore Hosp, Clin Pharmacokinet Lab, Buffalo, NY 14209 USA

[2] SUNY Buffalo, Sch Pharm, Buffalo, NY 14209 USA

来源：

CURRENT OPINION IN MICROBIOLOGY | 2000年 / 3卷 / 05期

关键词：

D O I：

10.1016/S1369-5274(00)00134-X

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Infections caused by multiple-resistant Gram-positive organisms continue to occur at an alarming rate worldwide. Two new and unique antimicrobial agents targeted specifically against such organisms, quinupristin/dalfopristin and linezolid, have been approved for use in the USA in the past year and will play an important role in the treatment of life-threatening infections. In addition, several new fluoroquinolones have been approved recently or will be available in the near future to aid in the treatment of infections caused by resistant strains of Streptococcus pneumoniae.

引用

页码：528 / 534

页数：7

共 77 条

[21] DEABATE CA, 1999, 39 INT C ANT AG CHEM, P177
[22] Oxazolidinones - A review
Diekema, DJ
Jones, RN
[J]. DRUGS, 2000, 59 (01) : 7 - 16
[23] Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997-98
Doern, GV
Brueggemann, AB
Huynh, H
Wingert, E
Rhomberg, P
[J]. EMERGING INFECTIOUS DISEASES, 1999, 5 (06) : 757 - 765
[24] DUVALL S, 2000, CLIN MICROBIOLOGY S1, V6, P64
[25] ENTENZA JM, 1999, 39 INT C ANT AG CHEM, P1489
[26] FILE T, 2000, M129 3 EUR C CHEM MA
[27] Fogarty C, 1999, INFECT MED, V16, P748
[28] FOGARTY C, 1999, 39 INT C ANT AG CHEM, P169
[29] FRIEDLAND IR, 1994, NEW ENGL J MED, V331, P377, DOI 10.1056/NEJM199408113310607
[30] Antimicrobial activity and spectrum of the new glycylcycline, GAR-936 tested against 1,203 recent clinical bacterial isolates
Gales, AC
Jones, RN
[J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2000, 36 (01) : 19 - 36

← 1 2 3 4 5 6 7 8 →